Markets decline in initial trade amid soaring inflation, foreign fund exodus
The Hindu
Equity markets decline on weak earnings, global trends; inflation hits 14-month high, foreign funds exit, oil prices rise.
Equity benchmark indices declined in early trade on Wednesday (November 13, 2024) amid retail inflation soaring to a 14-month high of 6.21% in October and unabated foreign fund outflows.
Muted quarterly earnings and weak trends in global markets were also the spoilsport for the markets, traders said.
The BSE benchmark Sensex declined 239.69 points to 78,435.49 in early trade. The NSE Nifty went down 103.15 points to 23,780.30.
From the 30-share Sensex pack, Mahindra & Mahindra, Maruti, Tata Steel, Sun Pharma, Nestle, and ITC were the biggest laggards.
Titan, HDFC Bank, Bharti Airtel, and NTPC were among the gainers.
Retail inflation breached the Reserve Bank's upper tolerance level, soaring to a 14-month high of 6.21% in October mainly on account of rising food prices.
Foreign Institutional Investors (FIIs) offloaded equities worth ₹3,024.31 crore on Tuesday, according to exchange data.
SBI, HDFC Bank, and ICICI Bank named as Domestic Systemically Important Banks with updated requirements by RBI.
USDINR pair volatile near all-time low of 84.40 due to global factors, RBI intervention, and weakening Dollar Index.
Equity markets decline on weak earnings, global trends; inflation hits 14-month high, foreign funds exit, oil prices rise.
Swiggy IPO debuts with a 7.69% jump at NSE, market valuation at ₹89,549.08 crore; shares listed at ₹412 on BSE.
Shares in Samsung Electronics fell on Wednesday to their lowest level in more than four years.
Mercedes-Benz India introduces the new Mercedes-AMG C 63 S E Performance sportscar with hybrid powertrain and innovative business model.
Hyundai Motor India Ltd. reports 16% profit decline in Q3 due to market sentiments, geopolitical factors, and Red Sea crisis.
Equity market plunges over 800 points, eroding market capitalisation by ₹5.29 lakh crore amid global economic concerns.
Aurobindo Pharma's CuraTeQ Biologics receives EMA GMP certificate for biosimilars, paving way for European approvals of three products.
BCCI to withdraw insolvency plea against Byju's after Supreme Court sets aside NCLAT judgement, NCLT hearing scheduled.
Natco Pharma's Q2 profits soar 83% to ₹676.5 crore, driven by robust exports and stable domestic business.